THE CORONARY-ARTERY RESPONSE TO IMPLANTATION OF A BALLOON-EXPANDABLE FLEXIBLE STENT IN THE ASPIRIN-TREATED AND NON-ASPIRIN-TREATED SWINE MODEL

被引:24
|
作者
RODGERS, GP
MINOR, ST
ROBINSON, K
CROMEENS, D
STEPHENS, LC
WOOLBERT, SC
GUYTON, JR
WRIGHT, K
SIEGEL, R
ROUBIN, GS
RAIZNER, AE
机构
[1] METHODIST HOSP, 6535 FANNIN, MS F-1000, HOUSTON, TX 77030 USA
[2] BAYLOR COLL MED, HOUSTON, TX 77030 USA
[3] EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA
[4] UNIV TEXAS, MD ANDERSON HOSP, CTR SCI, HOUSTON, TX 77025 USA
[5] UNIV ALABAMA, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1016/0002-8703(91)90506-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intracoronary stents may potentially alleviate some of the problems associated with coronary angioplasty. Since the anatomy and physiology of swine coronary arteries closely resemble those of humans, the response to implantation of the Gianturco-Roubin, balloon-expandable, flexible stent was studied in this model. Additionally, the effect of aspirin, 1 mg/kg/day orally, on this response was evaluated. Eighteen Hanford miniature swine underwent stenting of the left anterior descending coronary artery. Two died within 24 hours of stent implantation. The 16 survivors were put to death at 4 (n = 4), 11 (n = 4), 28 (n = 4), 56 (n = 3), and 180 (n = 1) days. Angiographically, reduction of stent lumen diameter of 0.1 to 1.3 mm was observed and was maximum at 11 days, with gradual improvement at subsequent time periods. Scanning electron microscopy, transmission electron microscopy, and light microscopy showed early disruption of subjacent endothelium, and adherence of platelets to exposed subendothelium and stent wires. Microthrombi were readily apparent. At 11 days, initimal thickening, made up predominantly of smooth muscle cells with abundant extracellular matrix, was observed and covered the stent wires. At 28 days, regression of intimal thickening was apparent and a confluent endothelium with flow-directed orientation was seen. At 56 and 180 days, the luminal surface was smooth; intimal thickening averaged 525-mu-m over the stent wires and 55-mu-m away from the wires. Findings in aspirin-treated animals were similar to results in those that did not receive aspirin. Thus in this swine model, stent implantation results in a time-dependent and self-limited vascular response.
引用
收藏
页码:640 / 647
页数:8
相关论文
共 25 条
  • [11] Comparison of the biocytex and the vaspfix assays of VASP phosphorylation in coronary-artery disease patients treated with clopidogrel plus aspirin
    Germanovich, K.
    Femia, E. A.
    Scavone, M.
    Caroppo, V
    Cattaneo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 784 - 785
  • [12] Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
    Jernberg, T
    Payne, CD
    Winters, KJ
    Darstein, C
    Brandt, JT
    Jakubowski, JA
    Naganuma, H
    Siegbahn, A
    Wallentin, L
    EUROPEAN HEART JOURNAL, 2006, 27 (10) : 1166 - 1173
  • [13] COMPARISON OF THE RESPONSE TO CORONARY-ARTERY BALLOON INJURY AND STENTING IN SWINE - AN ANIMAL-MODEL OF RESTENOSIS
    KARAS, SP
    GRAVANIS, MB
    ROBINSON, KA
    ANDERBERG, KA
    HEARN, JA
    KING, SB
    CIRCULATION, 1990, 82 (04) : 497 - 497
  • [14] Antiplatelet Efficacy of Fixed-Dose Aspirin–Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation
    Sungmin Lim
    Pum Joon Kim
    Chunyeong Baek
    Tae-Hoon Kim
    Yoon Seok Koh
    Hun-Jun Park
    Hee-Yeol Kim
    Kiyuk Chang
    Wook Sung Chung
    Ki-Bae Seung
    Clinical Drug Investigation, 2015, 35 : 833 - 842
  • [15] Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease
    Perneby, Christina
    Wallen, N. Hakan
    Hofman-Bang, Claes
    Tornvall, Per
    Ivert, Torbjoern
    Li, Nailin
    Hjemdahl, Paul
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) : 1316 - 1322
  • [16] Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes
    Eikelboom, JW
    Weitz, JI
    Budaj, A
    Zhao, F
    Copland, I
    Maciejewski, P
    Johnston, M
    Yusuf, S
    EUROPEAN HEART JOURNAL, 2002, 23 (22) : 1771 - 1779
  • [17] Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: Similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients
    Bernet, F
    Carrel, T
    Marbet, G
    Skarvan, K
    Stulz, P
    JOURNAL OF CARDIAC SURGERY, 1999, 14 (02) : 92 - 97
  • [18] Antiplatelet Efficacy of Fixed-Dose Aspirin-Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation
    Lim, Sungmin
    Kim, Pum Joon
    Baek, Chunyeong
    Kim, Tae-Hoon
    Koh, Yoon Seok
    Park, Hun-Jun
    Kim, Hee-Yeol
    Chang, Kiyuk
    Chung, Wook Sung
    Seung, Ki-Bae
    CLINICAL DRUG INVESTIGATION, 2015, 35 (12) : 833 - 842
  • [19] Antiplatelet Efficacy and Tolerability of Clopidogrel/aspirin Single-Pill Combination in Stable Patients With Coronary Artery Disease Treated With Drug- Eluting Stent Implantation
    Lim, Sungmin
    Kim, Dong Hwi
    Kim, Jae Gyung
    Kim, Jin Jin
    Choo, Eun Ho
    Na, Soo Jin
    Kim, Tae-Hun
    Koh, Yoon Seok
    Lee, Jong Min
    Lee, Su Nam
    Seo, Suk Min
    Shin, Dong Il
    Park, Mahn Won
    Ihm, Sang-Hyun
    Lee, Su-hyun
    Hwang, Byung-Hee
    Kim, Pum Joon
    Chung, Wook Sung
    Chang, Kiyuk
    Seung, Ki-Bae
    CIRCULATION, 2013, 128 (22)
  • [20] Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Brandt, John T.
    Braun, Oscar O.
    Man, Michael
    Siegbahn, Agneta
    Walker, Joseph
    Wallentin, Lars
    Winters, Kenneth J.
    Close, Sandra L.
    EUROPEAN HEART JOURNAL, 2009, 30 (14) : 1744 - 1752